U.S. stock futures rose on Wednesday with the Dow Jones, S&P 500, and Nasdaq 100 all posting gains. Investors await January FOMC minutes and Friday's PCE index release. Key movers include Ovintiv surging 4.17% after announcing a $3 billion asset sale, Tactile Systems jumping 23.53% on strong guidance, Celanese rising 5.94% despite earnings miss, and Palo Alto Networks falling 7.34% after lowering profit guidance.

Tactile Systems Technology (NASDAQ: TCMD) surged 23.35% in premarket trading to a new 52-week high following strong fourth-quarter earnings and the acquisition of LymphaTech. The company reported Q4 EPS of 46 cents (beating consensus of 44 cents) and sales of $103.59 million (up 21%, exceeding estimates of $93.80 million). The $6.8 million acquisition is expected to enhance lymphedema treatment capabilities. For fiscal 2026, the company forecasts sales of $357-$365 million and adjusted EBITDA of $49-$51 million, both above consensus expectations.

Tactile Systems Technology Inc. (NASDAQ: TCMD) has acquired LymphaTech Inc. for $6.8 million upfront plus potential milestone-based payments. LymphaTech's 3D digital measurement platform for lymphedema assessment will expand Tactile Medical's lymphedema portfolio, enabling more accurate disease identification and progression monitoring. The acquisition positions Tactile Medical as a comprehensive solutions leader for lymphatic dysfunction.

The article highlights three small-cap stocks with potential for growth in 2025, focusing on insider and institutional buying amid improving macroeconomic conditions and potential interest rate cuts.

Tactile Medical has announced the commercial availability of its next-generation pneumatic compression device, Nimbl, for the treatment of upper extremity lymphedema. Nimbl is significantly smaller, lighter, and more user-friendly than previous devices, and it has received FDA and CMS approvals.

The global compression therapy market is expected to reach a valuation of USD 6.26 billion by 2031, growing at a CAGR of 5.40% during the forecast period. The market is driven by the increasing cases of accidents and sports injuries, as well as the growing demand for compression garments and pumps.

Tactile Systems Technology, Inc. (Nasdaq: TCMD) announced that it will release its second quarter of fiscal year 2024 financial results on August 5, 2024, and host a conference call to discuss the results.

MINNEAPOLIS, May 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 44th Annual Growth Stock Conference, which is being held at the Loews Hotel in Chicago, IL from June 4th - 6th. Management will participate in a fireside chat on Tuesday, June 4th at 9:20 a.m. Central Time.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 54.55% and 3.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Tactile Systems Technology (TCMD) concluded the recent trading session at $14.44, signifying a +0.7% move from its prior day's close.

PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of 7.27% and 6.88%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?